Dana-Farber’s specialized treatment centers are staffed by teams of experts who work closely together to offer patients the latest therapies and strategies, including access to more than 1,100 therapeutic and non-therapeutic clinical trials.

“The extraordinary pace of innovations in cancer research and care can sometimes make it challenging for oncologists everywhere to keep up with rapidly evolving practices, especially if they are managing many types of cancer every day,” said Eric Winer, M.D., chief clinical development officer and Thompson Chair in Breast Cancer Research, Dana-Farber. “Through our new collaboration with AccessHope, Dana-Farber specialists can be helpful resources to community oncologists, particularly when treating patients with complex cancers. Joining forces with AccessHope is a part of our commitment to sharing the very latest science, extraordinary care and exceptional expertise with those who need it.”


The COVID-19 pandemic accelerated the rise in telehealth over the past year and a half, amplifying the need to rethink cancer care and the patient experience. Regardless of location, employees of AccessHope clients who are diagnosed with cancer, along with their local treating oncologist, can benefit from the expertise of specialists knowledgeable in the latest cancer discoveries for review of diagnosis, treatment plan and personalized precision medicine opportunities, as well as clinical trial information and support services. AccessHope's cancer support services help employees navigate the complexity of a cancer diagnosis to improve quality of life and health outcomes, help people return to their work and lives, and reduce expenses.

Today, AccessHope serves approximately 2.3 million plan members who have its cancer support services through 43 employers including Adobe and Pitney Bowes, and through collaborative relationships with Health Transformation Alliance and Quantum Health.

Following AccessHope’s national launch as a wholly owned subsidiary of City of Hope, Northwestern Medicine, a nationally recognized health system in Chicago that includes the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, was the first organization to join AccessHope as a foundational partner in the fall of 2020. Northwestern Medicine has extended its subspecialists’ expertise to AccessHope’s services throughout the Midwest, enabling AccessHope’s employer plan members and their treating oncologists to be matched with Northwestern Medicine and Lurie Cancer Center cancer specialists for case review and treatment plan recommendations.

Rad Oncology Homepage